InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,591.96
(
0.00%
)
US TECH 100
18,865.60
(
0.06%
)
Dow Jones
41,335.05
(
0.59%
)
Brent Oil
78.76
(
1.72%
)
Bitcoin
59,385.22
(
0.61%
)
Post# of 108192
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

James salmon

Send PM Follow Ignore
Followers 49
Posts 4473
Boards Moderated 0
Alias Born 03/20/2012

James salmon

Re: fbg0316 post# 69624

Friday, 06/01/2018 9:47:23 AM

Friday, June 01, 2018 9:47:23 AM

Post# of 108192
There is data regarding Keytruda being used on its own. Looking at this data though, I don’t think that these patients are as heavily pretreated as those on Advaxis trial.

http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.6_suppl.250
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ADXS News
More ADXS News
InvestorsHub NewsWire

Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM

Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!